Lymphocyte-depleted hodgkin's disease. Clinicopathologic review of 25 patients

John P. Greer, Marsha C Kinney, John B. Cousar, John M. Flexner, William D. Dupont, Stanley E. Graber, F. Anthony Greco, Robert D. Collins, Richard S. Stein

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Clinicopathologic material from 25 patients with lymphocyte-depleted Hodgkin's disease was reviewed. The median age of the patients was 57 years. The patients had no prior diagnosis of Hodgkin's disease and were divided according to pathologic subtype of lymphocyte-depleted Hodgkin's disease: 11 diffuse fibrosis, 10 reticular, and four not otherwise specified. The clinical presentation included B symptoms of fever, weight loss, or night sweats (92 percent), subdiaphragmatic disease (88 percent), frequent marrow involvement (56 percent), and advanced-stage disease (100 percent). Four of 11 patients with diffuse fibrosis had peripheral adenopathy as compared with seven of 10 patients with the reticular subtype (p = 0.3); 10 of 11 patients with diffuse fibrosis had marrow involvement compared with two of nine patients with the reticular subtype (p = 0.006). Among patients who received chemotherapy, median survival was longer in the diffuse fibrosis subtype (nine patients, 39 months) than in the reticular subtype (10 patients, 10 months), p = 0.005. Of the 17 patients who received more than one cycle of combination chemotherapy with mechlorethiamine, vincristine, procarbazine, and prednisone, the median survival was 36 months with 11 (65 percent) complete remissions. In eight patients, disease remains in remission (12 to 127 months) with five patients surviving beyond five years. These results indicate that lymphocyte-depleted Hodgkin's disease has at least two clinicopathologic subtypes and is curable if adequate therapy can be given.

Original languageEnglish (US)
Pages (from-to)208-214
Number of pages7
JournalThe American journal of medicine
Volume81
Issue number2
DOIs
StatePublished - 1986
Externally publishedYes

Fingerprint

Hodgkin Disease
Lymphocytes
Fibrosis
Bone Marrow
Procarbazine
Survival
Sweat
Vincristine
Prednisone
Combination Drug Therapy
Weight Loss
Fever

ASJC Scopus subject areas

  • Nursing(all)

Cite this

Greer, J. P., Kinney, M. C., Cousar, J. B., Flexner, J. M., Dupont, W. D., Graber, S. E., ... Stein, R. S. (1986). Lymphocyte-depleted hodgkin's disease. Clinicopathologic review of 25 patients. The American journal of medicine, 81(2), 208-214. https://doi.org/10.1016/0002-9343(86)90253-6

Lymphocyte-depleted hodgkin's disease. Clinicopathologic review of 25 patients. / Greer, John P.; Kinney, Marsha C; Cousar, John B.; Flexner, John M.; Dupont, William D.; Graber, Stanley E.; Greco, F. Anthony; Collins, Robert D.; Stein, Richard S.

In: The American journal of medicine, Vol. 81, No. 2, 1986, p. 208-214.

Research output: Contribution to journalArticle

Greer, JP, Kinney, MC, Cousar, JB, Flexner, JM, Dupont, WD, Graber, SE, Greco, FA, Collins, RD & Stein, RS 1986, 'Lymphocyte-depleted hodgkin's disease. Clinicopathologic review of 25 patients', The American journal of medicine, vol. 81, no. 2, pp. 208-214. https://doi.org/10.1016/0002-9343(86)90253-6
Greer, John P. ; Kinney, Marsha C ; Cousar, John B. ; Flexner, John M. ; Dupont, William D. ; Graber, Stanley E. ; Greco, F. Anthony ; Collins, Robert D. ; Stein, Richard S. / Lymphocyte-depleted hodgkin's disease. Clinicopathologic review of 25 patients. In: The American journal of medicine. 1986 ; Vol. 81, No. 2. pp. 208-214.
@article{bf413816aff0485f8f30db167641589a,
title = "Lymphocyte-depleted hodgkin's disease. Clinicopathologic review of 25 patients",
abstract = "Clinicopathologic material from 25 patients with lymphocyte-depleted Hodgkin's disease was reviewed. The median age of the patients was 57 years. The patients had no prior diagnosis of Hodgkin's disease and were divided according to pathologic subtype of lymphocyte-depleted Hodgkin's disease: 11 diffuse fibrosis, 10 reticular, and four not otherwise specified. The clinical presentation included B symptoms of fever, weight loss, or night sweats (92 percent), subdiaphragmatic disease (88 percent), frequent marrow involvement (56 percent), and advanced-stage disease (100 percent). Four of 11 patients with diffuse fibrosis had peripheral adenopathy as compared with seven of 10 patients with the reticular subtype (p = 0.3); 10 of 11 patients with diffuse fibrosis had marrow involvement compared with two of nine patients with the reticular subtype (p = 0.006). Among patients who received chemotherapy, median survival was longer in the diffuse fibrosis subtype (nine patients, 39 months) than in the reticular subtype (10 patients, 10 months), p = 0.005. Of the 17 patients who received more than one cycle of combination chemotherapy with mechlorethiamine, vincristine, procarbazine, and prednisone, the median survival was 36 months with 11 (65 percent) complete remissions. In eight patients, disease remains in remission (12 to 127 months) with five patients surviving beyond five years. These results indicate that lymphocyte-depleted Hodgkin's disease has at least two clinicopathologic subtypes and is curable if adequate therapy can be given.",
author = "Greer, {John P.} and Kinney, {Marsha C} and Cousar, {John B.} and Flexner, {John M.} and Dupont, {William D.} and Graber, {Stanley E.} and Greco, {F. Anthony} and Collins, {Robert D.} and Stein, {Richard S.}",
year = "1986",
doi = "10.1016/0002-9343(86)90253-6",
language = "English (US)",
volume = "81",
pages = "208--214",
journal = "American Journal of Medicine",
issn = "0002-9343",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Lymphocyte-depleted hodgkin's disease. Clinicopathologic review of 25 patients

AU - Greer, John P.

AU - Kinney, Marsha C

AU - Cousar, John B.

AU - Flexner, John M.

AU - Dupont, William D.

AU - Graber, Stanley E.

AU - Greco, F. Anthony

AU - Collins, Robert D.

AU - Stein, Richard S.

PY - 1986

Y1 - 1986

N2 - Clinicopathologic material from 25 patients with lymphocyte-depleted Hodgkin's disease was reviewed. The median age of the patients was 57 years. The patients had no prior diagnosis of Hodgkin's disease and were divided according to pathologic subtype of lymphocyte-depleted Hodgkin's disease: 11 diffuse fibrosis, 10 reticular, and four not otherwise specified. The clinical presentation included B symptoms of fever, weight loss, or night sweats (92 percent), subdiaphragmatic disease (88 percent), frequent marrow involvement (56 percent), and advanced-stage disease (100 percent). Four of 11 patients with diffuse fibrosis had peripheral adenopathy as compared with seven of 10 patients with the reticular subtype (p = 0.3); 10 of 11 patients with diffuse fibrosis had marrow involvement compared with two of nine patients with the reticular subtype (p = 0.006). Among patients who received chemotherapy, median survival was longer in the diffuse fibrosis subtype (nine patients, 39 months) than in the reticular subtype (10 patients, 10 months), p = 0.005. Of the 17 patients who received more than one cycle of combination chemotherapy with mechlorethiamine, vincristine, procarbazine, and prednisone, the median survival was 36 months with 11 (65 percent) complete remissions. In eight patients, disease remains in remission (12 to 127 months) with five patients surviving beyond five years. These results indicate that lymphocyte-depleted Hodgkin's disease has at least two clinicopathologic subtypes and is curable if adequate therapy can be given.

AB - Clinicopathologic material from 25 patients with lymphocyte-depleted Hodgkin's disease was reviewed. The median age of the patients was 57 years. The patients had no prior diagnosis of Hodgkin's disease and were divided according to pathologic subtype of lymphocyte-depleted Hodgkin's disease: 11 diffuse fibrosis, 10 reticular, and four not otherwise specified. The clinical presentation included B symptoms of fever, weight loss, or night sweats (92 percent), subdiaphragmatic disease (88 percent), frequent marrow involvement (56 percent), and advanced-stage disease (100 percent). Four of 11 patients with diffuse fibrosis had peripheral adenopathy as compared with seven of 10 patients with the reticular subtype (p = 0.3); 10 of 11 patients with diffuse fibrosis had marrow involvement compared with two of nine patients with the reticular subtype (p = 0.006). Among patients who received chemotherapy, median survival was longer in the diffuse fibrosis subtype (nine patients, 39 months) than in the reticular subtype (10 patients, 10 months), p = 0.005. Of the 17 patients who received more than one cycle of combination chemotherapy with mechlorethiamine, vincristine, procarbazine, and prednisone, the median survival was 36 months with 11 (65 percent) complete remissions. In eight patients, disease remains in remission (12 to 127 months) with five patients surviving beyond five years. These results indicate that lymphocyte-depleted Hodgkin's disease has at least two clinicopathologic subtypes and is curable if adequate therapy can be given.

UR - http://www.scopus.com/inward/record.url?scp=0022495033&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022495033&partnerID=8YFLogxK

U2 - 10.1016/0002-9343(86)90253-6

DO - 10.1016/0002-9343(86)90253-6

M3 - Article

C2 - 3740079

AN - SCOPUS:0022495033

VL - 81

SP - 208

EP - 214

JO - American Journal of Medicine

JF - American Journal of Medicine

SN - 0002-9343

IS - 2

ER -